Dozens of scientists are considering leaving the Center for Biologics Evaluation and Research, where Prasad serves as ...

A month’s supply of Miebo requires $800 and a prescription in the U.S. In Europe, it’s over-the-counter and $20.

Large private insurers have continued to call out purportedly overzealous coding and billing as a source of ballooning health ...

Health care has become a central issue in this year’s elections, a sign of parties' midterm strategies to come.

Merck, which has claimed bragging rights as the maker of the world’s best-selling drug, Keytruda, since 2023, has officially ...

A bidding war between Novo Nordisk and Pfizer has broken into the open for Metsera, which focuses on developing drugs to ...

A Thursday Senate hearing for President Trump's surgeon general pick, Casey Means, has been postponed because she went into ...

It’s no secret that our bodies’ ability to ward off pathogens and mount strong vaccine responses weakens with age, but ...

The stock market pummeled Cigna after the company revealed its new plan to ditch pharmacy benefit rebates will lower that ...

A new drug-sales king has been crowned. Eli Lilly’s diabetes and weight-loss drug tirzepatide, marketed under the Mounjaro ...

“Into 2026, we expect only modest sequential improvement,” wrote Evercore ISI’s Elizabeth Anderson, adding: “Management ...

The Trump administration has dismantled big chunks of the federal agency focused on mental health and addiction treatment, ...